ReachMD: The importance of extended genotyping in cervical cancer screening: The special case of HPV 31

Could an HPV test with extended genotyping that can individually identify HPV 16, 18, 31, and other genotypes change the way we manage cervical cancer screening results?

In this video, Dr. Mark Stoler, Professor of Pathology and Clinical Gynecology at the University of Virginia Health System, discusses the special case of HPV 31.

Latest resources

Discover our latest articles, webinars, press releases and updates in women's health.

Women's Health STIs
Vaginitis | Brochures
Get her vaginitis diagnosis right the first time with the BD Vaginal Panel
BD Onclarity HPV Assay
Cervical Cancer | News & Updates
Press Release: BD Onclarity™ HPV Assay Receives FDA Approval for Use with Both BD SurePath™ Liquid-based Pap Test and Hologic ThinPrep® Pap Test
Specimen collection for the BD CTGCTV2 assay
Specimen Collection for the BD CTGCTV2 Assay